1-20 of 17525
Sort by
Image
Published: 28 April 2025
Figure 1 OS, RFS, and LRC rates for all patients. The 5-year OS, RFS, and LRC rates were 49%, 31%, and 77%, respectively. OS: overall survival; RFS: recurrence -free survival; LRC: locoregional control.
Image
Published: 28 April 2025
Figure 2 OS and RFS rates by stage. The 5-year OS rates for Stages I–III and IV were 86% and 22%, respectively ( P  < .001). The 5-year RFS rates for Stages I–III and IV were 57% and 11%, respectively ( P  = .004). OS: overall survival; RFS: recurrence-free survival.
Journal Article
Shota Miyoshi and others
Japanese Journal of Clinical Oncology, hyaf068, https://doi.org/10.1093/jjco/hyaf068
Published: 28 April 2025
Journal Article
Laureline Gatellier and Kumiko Saika
Japanese Journal of Clinical Oncology, Volume 55, Issue 5, May 2025, Pages 560–561, https://doi.org/10.1093/jjco/hyaf062
Published: 26 April 2025
Image
Published: 26 April 2025
Figure 1 Age-standardized mortality-to-incidence rate for esophagus cancer in 2022.
Image
Published: 23 April 2025
Figure 1 Average positional shifts on X-axis for Head and Neck, Chest, and Pelvic groups with standard deviations. This figure shows the average deviation in the x-axis for three treatment groups (Head and Neck, Chest, and Pelvis). Each panel represents the individual cases in the respective groups, with err
Image
Published: 23 April 2025
Figure 3 Average positional shifts on Z-axis for Head and Neck, Chest, and Pelvic groups with standard deviations. This figure illustrates the average deviation in the z-axis for the three treatment groups (Head and Neck, Chest, and Pelvis), with error bars representing the standard deviation for each case.
Journal Article
Hisanori Fukunaga and Mayuko Fukunaga
Japanese Journal of Clinical Oncology, hyaf066, https://doi.org/10.1093/jjco/hyaf066
Published: 23 April 2025
Journal Article
Duong Thanh Tai and others
Japanese Journal of Clinical Oncology, hyaf067, https://doi.org/10.1093/jjco/hyaf067
Published: 23 April 2025
Image
Published: 23 April 2025
Figure 1 Distribution of mitochondrial DNA copy number (mtDNA-CN). (A) Scatter plot showing the distribution of mtDNA-CN according to patient age. (B) Box-and-whisker plot comparing mtDNA-CN in gastric cancer tissues between male and female patients. (C) Paired comparison of mtDNA copy number between tumor a
Image
Published: 23 April 2025
Figure 5 Distribution of positional shifts in x, y, and z axes for a single group (Head and Neck (a), Chest (b), and Pelvis (c)).
Image
Published: 23 April 2025
Figure 2 Comparison of mtDNA copy number (mtDNA-CN) according to tumor stage, Laurén classification, and HER2 status. (A) Box-and-whisker plot showing the distribution of mtDNA-CN by tumor stage. (B) Box-and-whisker plot comparing mtDNA-CN between diffuse-type and intestinal-type gastric cancers, based on
Image
Published: 23 April 2025
Figure 2 Average positional shifts on Y-axis for Head and Neck, Chest, and Pelvic groups with standard deviations. This figure illustrates the average deviation in the y-axis for three treatment groups (Head and Neck, Chest, and Pelvis), with error bars representing the standard deviation of the positional s
Image
Published: 23 April 2025
Figure 4 Normalized density distributions of positional shifts in x (a), y (b), and z (c) axes for Head and Neck, Chest, and Pelvic groups. This figure compares the normalized density distributions of positional shifts across the x-axis, y-axis, and z-axis between the Head and Neck, Chest, and Pelvic treatme
Journal Article
Ting Qu and others
Japanese Journal of Clinical Oncology, hyaf063, https://doi.org/10.1093/jjco/hyaf063
Published: 20 April 2025
Image
Published: 20 April 2025
Figure 4 Forest plot of pooled (A) the sensitivity and specificity, (B) the positive and negative diagnosis likelihood ratio, and (C) the diagnostic score and odds ratio of CNSs in SLNB of cervical cancer.
Image
Published: 20 April 2025
Figure 5 Summary of the receiver operating characteristic plot of CNSs in SLNB of cervical cancer.
Image
Published: 20 April 2025
Figure 1 Preferred reporting items for systematic reviews and meta-analyses flowcharts of the article search process.
Image
Published: 20 April 2025
Figure 2 Forest plot for the (A) overall detection rate and (B) bilateral and unilateral detection rate of CNSs in SLNB of cervical cancer.
Image
Published: 20 April 2025
Figure 3 Subgroup analysis of the detection rate of CNSs in SLNB of cervical cancer, stratified by (A) lesion size and (B) the administration of neoadjuvant chemotherapy.